New Treatment Shows No Benefit for Clear Cell Carcinoma
New Treatment Shows No Benefit for Clear Cell Carcinoma
(July 18, 2016) The first randomized phase III clinical trial to compare irinotecan and cisplatin with paclitaxel plus carboplatin in patients with clear cell carcinoma (CCC) of the ovary found … Continued